Hospital  >  Welcome  >  Safety, Quality, Strategy, and Management  >  Strategic Plan - 2021-2025  >  Measuring Our Success

Strategic Performance Report: Q1-Q4 Fiscal Year 2021-2022 Results

Click here to read a text-only version of this infographic

Strategy Performance Report: Q1-Q4 Fiscal Year 2021-2022 Results

Strategic Direction 1: Personalized and Precise Treatments

  1. Number of Personalized and Precise Treatment (PPT) clinical volumes 
    Growth in these areas represents the expansion of personalized and precise treatments for our patients.
    Cancer Ablation Therapy: 928 (Target ≥ 900)
    Focused Ultrasound: 48 (Target ≥ 48)
    Minimally Invasive Structural Heart: 394 (Target ≥ 437)

  2. Number of new clinical and pre-clinical trials initiated
    Growth in our clinical trials increases the likelihood of setting new personalized and precise standards of care.
    Number of new clinical and pre-clinical trials initiated: 74 (Target ≥ 72)

Strategic Direction 2: Integrated and Sustainable Models of Care

  1. Number of patients receiving specialized/ complex care within select clinics
    Increasing the number of patients treated by these clinics represents increasing support for patients in need of specialized and complex care.
    Jennifer Tory Trauma Clinic: 1,887 (Target ≥ 1,760)
    Vascular Limb Preservation Program: 98 (Target ≥ 208)
    Neonatal Follow-up Clinic: 2,388 (Target ≥ 2,200)

  2. Number of patient consults/visits within a collaborative North Toronto Ontario Health Team program
    Growth in the number of patients cared for will help minimize the need for hospitalizations and prevent the need for emergency care.
    High Intensity Support @Home: 304 (Target ≥ 390)
    ED One Team: 3,870 (Target ≥ 3,540)

Strategic Direction 3: Improve Quality and Create a Better Care Experience

  1. Percent of patients with demographic data collected in new areas across the organization by March 2022
    Growth in the percentage of patients providing this information will inform program design and delivery, identify areas of inequity, and tailor services to meet the needs of our patients.
    0% (Target ≥ 75%)

  2. Number of unit-level patient experience dashboards launched
    Increasing the deployment of an innovative patient experience dashboard improves our ability to take action to improve experience.
    0 (Target ≥ 10)

  3. Number of virtual health patient visits
    Growth in virtual patient visits for appropriate clinical activity represents increasing acceptance of novel approaches to providing care in a manner that best meets patient needs.
    Virtual ED: 1,906 (Target ≥ 1,500)
    Oncology Clinics: 75,208 (Target ≥ 37,000)
    Family Navigation Project: 822 (Target ≥ 746)

Strategic Direction 4: High Performing Teams

  1. Number of staff trained/ mentored within Sunnybrook in the area of equity, diversity and inclusion
    Increasing the number of staff trained/ mentored will help develop Sunnybrookers to recognize and challenge racism within our organization.
    421 (Target ≥ 300)

  2. Number of team simulations
    Increasing the number of simulations represents growth in our collaborative efforts to improve the health care system and provide world class care for residents of Ontario.
    670 (Target ≥ 530)

Illustrating progress: a patient story

As a former broadcaster, David Onley has always prided himself on the strength of his voice. He had also served as Ontario’s 28th Lieutenant Governor, living a very public life. But in 2017, he started noticing a steep and rapid decline in his health and functioning. His voice weakened, and he nearly drowned in his bathtub because of his declining physical state.

Following a series of tests at Sunnybrook, a brain tumor the size of an orange was detected. David had immediate surgery to remove this non-cancerous meningioma, and then was advised to receive follow up radiation through the MOMENTUM study. The study focuses on a technology called the MR-Linac Elekta Unity, the first machine in the world to combine radiation and high-resolution MRI imaging. It’s a huge advance in precision as it allows the clinical team to see the tumor each day before it’s treated.

Dr. Arjun Sahgal, radiation oncologist and head of the Cancer Ablation Therapy Program, says being able to see the tumor each day results in a change in the medicine or actual radiation treatment plan thirty to forty percent of the time.

David underwent daily treatments that were given over several weeks. He says he took time to learn about the MR-Linac, and the precision of this approach gave him a lot of comfort. He says he’s once again stepping into the public eye by sharing his story, hoping it will help raise awareness for others.